Louapre III Rene A MD New Orleans, LA - 70115

Louapre III Rene A MD is categorized under Internal Medicine Doctors in New Orleans, LA and active since 1995.

Louapre III Rene A MD was established in 1995, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Rene Louapre III at the company’s single location by writing to 2633 Napoleon Avenue # 400, New Orleans, Louisiana LA 70115 or by phoning (504) 897-3305. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Louapre III Rene A MD
Contact Person: Rene Louapre III
Address: 2633 Napoleon Avenue # 400, New Orleans, Louisiana 70115
Phone Number: (504) 897-3305
Website Address: imdocs.net
Annual Revenue (USD): $500.000 to $999.999
Founded: 1995
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Louapre III Rene A MD was started in 1995 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Rene Louapre III for inquiries that concern Louapre III Rene A MD by calling the company number (504) 897-3305, as your correspondence is most welcome. Additionally, the physical location of the single location of Louapre III Rene A MD can be found at the coordinates 29.936588,-90.102912 as well as the street address 2633 Napoleon Avenue # 400 in New Orleans, Louisiana 70115.

For its online presence, you may visit Louapre III Rene A MD’s website at imdocs.net and engage with its social media outlets through on Twitter and on Facebook.